PBI
58
8
DRI
63
3
GOOG
75
2
FMC
31
-3
MS
70
-2
MAS
51
-11
REGN
65
2
MMC
70
2
PFE
37
-3
MCD
46
-3
EQT
57
3
XEL
60
-2
C
48
-2
BLK
69
11
KSS
47
-4
HES
68
2
DLTR
44
-7
NWL
35
-4
CVS
43
2
PGR
68
3
PBI
58
8
DRI
63
3
GOOG
75
2
FMC
31
-3
MS
70
-2
MAS
51
-11
REGN
65
2
MMC
70
2
PFE
37
-3
MCD
46
-3
EQT
57
3
XEL
60
-2
C
48
-2
BLK
69
11
KSS
47
-4
HES
68
2
DLTR
44
-7
NWL
35
-4
CVS
43
2
PGR
68
3
Financhill
Back

Replimune Group Vs. Esperion Therapeutics Industry Stock Comparison

Sell
22

REPL
Replimune Group

Last Price:
6.43
Seasonality Move:
4.2%
Sell
38

ESPR
Esperion Therapeutics

Last Price:
2.35
Seasonality Move:
-7.21%
Sell
22
Replimune Group (REPL) is a Sell

Is Replimune Group a Buy, Sell or Hold?

  • The current Replimune Group [REPL] share price is $6.44. The Score for REPL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Esperion Therapeutics (ESPR) is a Sell

Is Esperion Therapeutics a Buy, Sell or Hold?

  • The current Esperion Therapeutics [ESPR] share price is $2.36. The Score for ESPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ESPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REPL Stock Price Chart

What is Replimune Group's stock price today?

  • The Replimune Group share price today is $6.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.

ESPR Stock Price Chart

What is Esperion Therapeutics's stock price today?

  • The Esperion Therapeutics share price today is $2.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing selling pressure, which indicates risk of future bearish movement.

REPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 41.62 Sell
Chaikin Money Flow: -781303 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.38 - 6.94) Sell
Bollinger Bands (100): (6.9 - 8.56) Sell

ESPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.1 Buy
Chaikin Money Flow: -6348759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.91 - 2.27) Buy
Bollinger Bands (100): (2.06 - 2.74) Sell

REPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 6.58 Sell
50-day SMA: 7.3 Sell
200-day SMA: 11.23 Sell
8-day EMA: 6.64 Sell
20-day EMA: 6.73 Sell
50-day EMA: 7.17 Sell
200-day EMA: 10.77 Sell

ESPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.25 Buy
20-day SMA: 2.13 Buy
50-day SMA: 2.28 Buy
200-day SMA: 1.84 Buy
8-day EMA: 2.29 Buy
20-day EMA: 2.22 Buy
50-day EMA: 2.26 Buy
200-day EMA: 2.26 Buy

Replimune Group Earnings Growth & REPL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.12 per share.

Esperion Therapeutics Earnings Growth & ESPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.08 per share, an increase this year of $2.00 per share, and an increase next year of $0.23 per share.

Replimune Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Esperion Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):